Biosimilars no longer need to be reviewed by CADTH.

For industry, the path of the biologic prescription, once written, may see a number of influence points that affect market share, marketing plans, patient support programs (PSPs) and prescribers.

Ontario’s Ministry of Health and Long-Term Care (MOHLTC) has proposed legislation regarding pharmacy reimbursement and payment policies.

The sale of Canadian prescription drugs to US citizens continues to garner attention from the FDA, US Senators, the media and American patients.

The Feds are amending the Food and Drug Regulations to improve access to generics.

The Ministry of Health and Long-Term Care released a list of FAQs for Ontario patients to better understand the upcoming changes of OHIP+, that are to be implemented April 1, 2019.

Following the review of more than 100 submissions and 700 comments, Health Canada has considered the divergent views of various sectors to the October 2017 fee proposal and released its revisions.

In 2015, researcher Jean-Christophe Beaisle-Pipon made a request of the Quebec Access to Information Commission seeking the price paid by the Quebec government for a dose of Bexsero (meningococcal) vaccine (GSK).

It's well documented that the use of specialty medications, however defined, will continue to rise. This is a great news story for patients and the health care practitioners who manage the treatment of some life-changing conditions.

Medical Science Liaisons (MSLs) have been around for about 50 years. Upjohn Pharmaceuticals first created this unique position in 1967, aimed at building relationships and research collaborations with Key Opinion Leaders (KOLs).